Adults over age 50 who experience mild or moderate COVID-19 are at greater risk of worsening mobility and physical function even if hospitalization is not required to treat the virus, according to new research out of Dalhousie and other Canadian universities.
A group of scholars and researchers co-led by a Dalhousie professor has joined forces in an effort to re-shape medical and health education in Canada to better reflect the impacts of anti-Black racism on the delivery of care for African Nova Scotians and Black people.
This October, as part of Women's History Month in Canada, learn more about Jeanette Boudreau, an assistant professor in the Department of Microbiology and Immunology and Department of Pathology in the Faculty of Medicine.
Associate professor in the Department of Community Health & Epidemiology at Dalhousie Medical School Dr. Bradley Johnston, recently found that certain multi-species probiotics reduce the odds of C. difficile infection by about two-thirds.
Five researchers from Dalhousie are receiving new funding to acquire the cutting-edge tools needed to conduct world-class research through the Canada Foundation for Innovation's John R. Evans Leaders Fund.
A cross-Canada study led by Dalhousie Medical School researchers has proven that Aspirin is as effective as rivaroxaban in preventing blood clots after hip and knee replacement surgery — a finding which could mean substantial cost savings for patients.